OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions

Karine Toupin-April, Jennifer L. Barton, Liana Fraenkel, Alexa Meara, Linda C. Li, Peter Brooks, Maarten de Wit, Dawn Stacey, France Légaré, Beverley Shea, Anne Lyddiatt, Cathie Hofstetter, Robin Christensen, Marieke Scholte Voshaar, Maria E. Suarez-Almazor, Annelies Boonen, Tanya Meade, Lyn March, Janet Elizabeth Jull, Willemina CampbellRieke Alten, Suvi Karuranga, Esi M. Morgan, Ayano Kelly, Jessica Kaufman, Sophie Hill, Lara J. Maxwell, Dorcas Beaton, Yasser El-Miedany, Shikha Mittoo, Susan J. Bartlett, Jasvinder A. Singh, Peter S. Tugwell

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group aims to determine the core outcome domain set for measuring the effectiveness of SDM interventions in rheumatology trials. Methods. A white paper was developed to clarify the draft core domain set. It was then used to prepare for interviews to investigate reasons for lack of consensus on it and to suggest further improvements. Results. OMERACT scientists/clinicians (n = 13) and patients (n = 10) suggested limiting the core domain set to outcome domains, removing process domains, and clarifying remaining domains. Conclusion. A revised core domain set will undergo further consensus-building.

Original languageEnglish (US)
Pages (from-to)1409-1414
Number of pages6
JournalJournal of Rheumatology
Volume46
Issue number10
DOIs
StatePublished - 2019

Keywords

  • Omeract
  • Outcomes
  • Rheumatic diseases

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions'. Together they form a unique fingerprint.

Cite this